As of 2025-08-04, the Intrinsic Value of Athira Pharma Inc (ATHA) is -8.25 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.37 USD, the upside of Athira Pharma Inc is -2,329.85%.
Based on its market price of 0.37 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 2,329.85%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -8.25 - -8.25 | -8.25 | -2,329.85% |
| P/E | (29.59) - (30.25) | (30.96) | -8462.0% |
| DDM - Stable | (13.18) - (36.85) | (25.02) | -6857.4% |
| DDM - Multi | (14.10) - (31.17) | (19.47) | -5360.5% |
| Market Cap (mil) | 17.88 |
| Beta | 2.43 |
| Outstanding shares (mil) | 48.30 |
| Enterprise Value (mil) | -8.54 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.40% |
| Cost of Debt | 5.00% |
| WACC | 7.04% |